Cargando…

Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation

We aimed to investigate the potential mechanisms of progression and identify novel prognosis-related biomarkers for papillary renal cell carcinoma (PRCC) patients. The related data were derived from The Cancer Genome Atlas (TCGA) and then analyzed by weighted gene coexpression network analysis (WGCN...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xingliang, Zhang, Meng, Meng, Jialin, Wang, Yongqiang, Liu, Yi, Liang, Chaozhao, Fan, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851515/
https://www.ncbi.nlm.nih.gov/pubmed/31948514
http://dx.doi.org/10.3727/096504020X15791676105394
_version_ 1783645646659518464
author Feng, Xingliang
Zhang, Meng
Meng, Jialin
Wang, Yongqiang
Liu, Yi
Liang, Chaozhao
Fan, Song
author_facet Feng, Xingliang
Zhang, Meng
Meng, Jialin
Wang, Yongqiang
Liu, Yi
Liang, Chaozhao
Fan, Song
author_sort Feng, Xingliang
collection PubMed
description We aimed to investigate the potential mechanisms of progression and identify novel prognosis-related biomarkers for papillary renal cell carcinoma (PRCC) patients. The related data were derived from The Cancer Genome Atlas (TCGA) and then analyzed by weighted gene coexpression network analysis (WGCNA). The correlation between each module and the clinical traits were analyzed by Pearson’s correlation analysis. Pathway analysis was conducted to reveal potential mechanisms. Hub genes within each module were screened by intramodule analysis, and visualized by Cytoscape software. Furthermore, important hub genes were validated in an external dataset and clinical samples. A total of 5,839 differentially expressed genes were identified. By using WGCNA, we identified 21 coregulatory gene clusters based on 289 PRCC samples. We found many modules were significantly associated with clinicopathological characteristics. The gray, pink, light yellow, and salmon modules served as prognosis indicators for PRCC patients. Pathway enrichment analyses found that the hub genes were significantly enriched in the cancer-related pathways. With the external Gene Expression Omnibus (GEO) validation dataset, we found that PCDH12, GPR4, and KIF18A in the pink and yellow modules were continually associated with the survival status of PRCC, and their expressions were positively correlated with pathological grade. Notably, we randomly chose PCDH12 for validation, and the results suggested that the PRCC patients with higher pathological grades (II + III) mostly had higher PCDH12 protein expression levels compared with those patients in grade I. These validated hub genes play critical roles in the prognosis prediction of PRCC and serve as potential biomarkers for future personalized treatment.
format Online
Article
Text
id pubmed-7851515
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cognizant Communication Corporation
record_format MEDLINE/PubMed
spelling pubmed-78515152021-02-16 Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation Feng, Xingliang Zhang, Meng Meng, Jialin Wang, Yongqiang Liu, Yi Liang, Chaozhao Fan, Song Oncol Res Article We aimed to investigate the potential mechanisms of progression and identify novel prognosis-related biomarkers for papillary renal cell carcinoma (PRCC) patients. The related data were derived from The Cancer Genome Atlas (TCGA) and then analyzed by weighted gene coexpression network analysis (WGCNA). The correlation between each module and the clinical traits were analyzed by Pearson’s correlation analysis. Pathway analysis was conducted to reveal potential mechanisms. Hub genes within each module were screened by intramodule analysis, and visualized by Cytoscape software. Furthermore, important hub genes were validated in an external dataset and clinical samples. A total of 5,839 differentially expressed genes were identified. By using WGCNA, we identified 21 coregulatory gene clusters based on 289 PRCC samples. We found many modules were significantly associated with clinicopathological characteristics. The gray, pink, light yellow, and salmon modules served as prognosis indicators for PRCC patients. Pathway enrichment analyses found that the hub genes were significantly enriched in the cancer-related pathways. With the external Gene Expression Omnibus (GEO) validation dataset, we found that PCDH12, GPR4, and KIF18A in the pink and yellow modules were continually associated with the survival status of PRCC, and their expressions were positively correlated with pathological grade. Notably, we randomly chose PCDH12 for validation, and the results suggested that the PRCC patients with higher pathological grades (II + III) mostly had higher PCDH12 protein expression levels compared with those patients in grade I. These validated hub genes play critical roles in the prognosis prediction of PRCC and serve as potential biomarkers for future personalized treatment. Cognizant Communication Corporation 2020-05-29 /pmc/articles/PMC7851515/ /pubmed/31948514 http://dx.doi.org/10.3727/096504020X15791676105394 Text en Copyright © 2020 Cognizant, LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License.
spellingShingle Article
Feng, Xingliang
Zhang, Meng
Meng, Jialin
Wang, Yongqiang
Liu, Yi
Liang, Chaozhao
Fan, Song
Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
title Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
title_full Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
title_fullStr Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
title_full_unstemmed Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
title_short Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
title_sort correlating transcriptional networks to papillary renal cell carcinoma survival: a large-scale coexpression analysis and clinical validation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851515/
https://www.ncbi.nlm.nih.gov/pubmed/31948514
http://dx.doi.org/10.3727/096504020X15791676105394
work_keys_str_mv AT fengxingliang correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation
AT zhangmeng correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation
AT mengjialin correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation
AT wangyongqiang correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation
AT liuyi correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation
AT liangchaozhao correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation
AT fansong correlatingtranscriptionalnetworkstopapillaryrenalcellcarcinomasurvivalalargescalecoexpressionanalysisandclinicalvalidation